12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's pre-market session, several healthcare stocks experienced significant movements. Ontrak, Bio-Path Holdings, and Virios Therapeutics saw notable gains, while Vincerx Pharma, Sage Therapeutics, and LogicMark faced declines.
October 08, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
LogicMark stock decreased by 10.64% to $0.12, showing a downturn in pre-market trading.
The decrease in LogicMark's stock price suggests negative sentiment, likely leading to short-term losses.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Sage Therapeutics stock fell 11.57% to $5.94, reflecting a negative market reaction.
Sage Therapeutics' significant pre-market decline indicates a negative market response, suggesting potential short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Vincerx Pharma stock decreased by 15.5% to $0.59, indicating negative market sentiment.
The decline in Vincerx Pharma's stock price suggests negative sentiment or news, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Bio-Path Holdings stock rose 51.53% to $1.29, reflecting a positive market reaction.
The substantial increase in Bio-Path Holdings' stock price indicates a favorable market response, suggesting potential short-term gains.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Ontrak shares rose 63.7% to $2.98 in pre-market trading, indicating strong investor interest.
Ontrak's significant pre-market price increase suggests positive sentiment or news, likely leading to short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Virios Therapeutics stock increased by 34.8% to $0.19, showing strong pre-market performance.
Virios Therapeutics' significant pre-market rise suggests positive investor sentiment, likely leading to short-term gains.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100